BRIEF-Genezen To Acquire Uniqure's Commercial Gene Therapy Manufacturing Operations In Lexington, Ma-February 2024-www.financetom.com

BRIEF-Genezen To Acquire Uniqure's Commercial Gene Therapy Manufacturing Operations In Lexington, Ma

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Genezen To Acquire Uniqure's Commercial Gene Therapy Manufacturing Operations In Lexington, Ma

Jul 1, 2024 4:30 AM

July 1 (Reuters) - Uniqure NV ( QURE ):

* GENEZEN TO ACQUIRE UNIQURE'S COMMERCIAL GENE THERAPY

MANUFACTURING OPERATIONS IN LEXINGTON, MA

* TRANSACTION FUNDED IN PART BY ADDITIONAL GROWTH EQUITY

FROM

AMPERSAND CAPITAL

Source text for Eikon:

Further company coverage:

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Harley-Davidson posts lower second-quarter profit

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Harley-Davidson posts lower second-quarter profit

Jul 30, 2025

July 30 (Reuters) - Harley-Davidson ( HOG ) reported a lower second-quarter profit on Wednesday, as U.S. President Donald Trump's tariffs continued to weigh on the motorcycle maker. Its quarterly profit fell to $108 million, or 88 cents per share, from $218 million, or $1.63 per share, a year ago. ...

Investment bank Evercore beats Q2 revenue estimates, announces acquisition of Robey Warshaw

Jul 30, 2025

Overview * Evercore Q2 2025 revenue grows 21% yr/yr, beating analyst expectations * Adjusted EPS for Q2 2025 beats consensus, driven by large transactions * Co announces acquisition of Robey Warshaw, expanding UK advisory capabilities Outlook * Evercore ( EVR ) continues to experience strong momentum in advisory business * Company sees ongoing momentum with significant advisory roles in July...

Axalta Coating Q2 non-GAAP Earnings Rise, Revenue Falls

Jul 30, 2025

06:54 AM EDT, 07/30/2025 (MT Newswires) -- Axalta Coating Systems ( AXTA ) reported Q2 non-GAAP earnings Wednesday of $0.64 per diluted share, up from $0.61 per share a year earlier. Analysts surveyed by FactSet expected $0.61. Revenue for the quarter ended June 30 was $1.31 billion, down from $1.35 billion a year earlier. Analysts surveyed by FactSet expected $1.32...